We are live on ! Find out more
IMVT icon

Immunovant
IMVT

110 hedge funds and large institutions have $407M invested in Immunovant in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

538% more call options, than puts

Call options by funds: $56.4M | Put options by funds: $8.84M

45% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 31

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.93% less ownership

Funds ownership: 41.29% → 39.35% (-1.9%)

8% less funds holding

Funds holding: 120 → 110 (-10)

32% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 31

38% less capital invested

Capital invested by funds: $653M → $407M (-$246M)

Holders
110
Holders Change
-10
Holders Change %
-8.33%
% of All Funds
1.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
45
Reduced
31
Closed
31
Calls
$56.4M
Puts
$8.84M
Net Calls
+$47.6M
Net Calls Change
+$39M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$39.8M
2
AGM
Alpine Global Management
New York
+$12.6M
3
EAM
Eventide Asset Management
Massachusetts
+$12.5M
4
Morgan Stanley
Morgan Stanley
New York
+$11M
5
State Street
State Street
Massachusetts
+$10.8M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$102M
2
Goldman Sachs
Goldman Sachs
New York
-$11.7M
3
BlackRock
BlackRock
New York
-$8.13M
4
CS
Candriam SCA
Luxembourg
-$8.06M
5
OM
Opaleye Management
Massachusetts
-$7.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCMV
126
Foresite Capital Management V
California
– -$802K -50,000 Closed
ACM
127
AlphaCrest Capital Management
New York
– -$629K -39,200 Closed
OQS
128
Occudo Quantitative Strategies
Florida
– -$405K -25,254 Closed
D.E. Shaw & Co
129
D.E. Shaw & Co
New York
– -$403K -25,119 Closed
MCM
130
Moore Capital Management
New York
– -$387K -24,113 Closed
Prudential Financial
131
Prudential Financial
New Jersey
– -$290K -18,114 Closed
E
132
Ergoteles
New York
– -$237K -14,800 Closed
Los Angeles Capital Management
133
Los Angeles Capital Management
California
– -$223K -13,880 Closed
Allianz Asset Management
134
Allianz Asset Management
Germany
– -$218K -13,620 Closed
CM
135
Caption Management
Oklahoma
– -$120K -8,600 Closed
SFS
136
Sowell Financial Services
Arkansas
– -$100K -6,092 Closed
Pacer Advisors
137
Pacer Advisors
Pennsylvania
– -$74K -4,594 Closed
SM
138
SG3 Management
Puerto Rico
– -$34.9K -2,500 Closed
Bank of Montreal
139
Bank of Montreal
Ontario, Canada
– -$29K -1,815 Closed
ADIM
140
Alpha DNA Investment Management
Maryland
– -$3K -193 Closed
2 3 4 5
6

IMVT Hedge Fund Activity: Q2 2021 in Review

110 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q2 2021, worth a combined $407M — down 38% from $653M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of IMVT and 21 opened new positions — a net loss of 10 holders — while 31 trimmed existing stakes and 45 added.

The largest buyer was Woodline Partners, adding an estimated $39.8M. The largest seller was RTW Investments, exiting entirely with an estimated $102M sold.

  • 110 institutional investors held Immunovant (IMVT) as of Q2 2021, down from 120 in Q1 2021.
  • Funds reported $407M of Immunovant stock for Q2 2021, down 38% quarter-over-quarter.
  • 21 funds opened new Immunovant positions in Q2 2021 and 31 closed out, a net change of -10 holders.
  • The largest Immunovant buyer in Q2 2021 was Woodline Partners, an estimated $39.8M added.
  • The largest Immunovant seller in Q2 2021 was RTW Investments, an estimated $102M sold.

Based on aggregated 13F filings for Q2 2021.